PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 140 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $13,071,000 | -64.8% | 285,091 | -54.5% | 1.41% | -1.9% |
| Q2 2018 | $37,084,000 | +29.1% | 626,950 | +48.6% | 1.43% | +25.9% |
| Q1 2018 | $28,715,000 | +228.5% | 421,966 | +322.0% | 1.14% | +578.0% |
| Q2 2017 | $8,740,000 | -48.5% | 100,000 | -78.1% | 0.17% | -61.6% |
| Q1 2017 | $16,967,000 | +23.2% | 456,097 | +1.7% | 0.44% | +64.9% |
| Q4 2016 | $13,768,000 | -21.3% | 448,471 | -23.6% | 0.26% | -24.3% |
| Q2 2016 | $17,490,000 | +319.8% | 587,126 | +1367.8% | 0.35% | +79.5% |
| Q1 2014 | $4,166,000 | – | 40,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |